Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Sotera Health receives a "buy" rating upgrade, with analysts setting a $16.00 target price.
Sotera Health (NASDAQ: SHC) has been upgraded to a "buy" rating by Wall Street Zen, with an average target price of $16.00.
The company recently reported EPS of $0.14, beating estimates by $0.02, and has a market cap of $3.21 billion.
Sotera Health provides sterilization, lab testing, and advisory services.
2 Articles
Sotera Health recibe una mejora de calificación de "comprar", con los analistas estableciendo un precio objetivo de $16.00.